Avacta Group Plc AVCTF
0.77 USD 0.00 (+0.00%)
At closeNov 9, 2026, 4:00 PM EST
0.77 Day range 0.77
0.7384 52-week range 1.23
- YTD
- -1.02%
- 1 year
- -26.67%
News
seekingalpha.com Avacta Group Plc (AVCTF) Q2 2026 Earnings Call Transcript Avacta Group Plc (AVCTF) Q2 2026 Earnings Call Transcript
defenseworld.net Avacta Group Plc (OTCMKTS:AVCTF) Stock Short Interest Report for September Avacta Group Plc (OTCMKTS:AVCTF - Get Free Report) was the target of a significant increase in short interest in September. As of September 30th, there was short interest totaling 10 shares. Based on…
globenewswire.com Avacta Appoints Healthcare Executive Patrick Vink as Deputy Chairman of the Board of Directors LONDON and PHILADELPHIA, July 08, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, "the Company", "Avacta"), a clinical stage biopharmaceutical company developing pre|CISION®, a…
globenewswire.com Avacta presents updated clinical data showing encouraging early efficacy signals for AVA6000 in salivary gland cancers at ASCO 2026 Multiple confirmed partial and minor responses observed in patients with SGC Continuing very good safety profile, with removal of the lifetime maximum doxorubicin limit based on highly favorable…
seekingalpha.com Avacta Group Plc (AVCTF) Q4 2025 Earnings Call Transcript Avacta Group Plc (AVCTF) Q4 2025 Earnings Call Transcript
globenewswire.com Unaudited Preliminary Results for the Year Ended December 31, 2025 LONDON and PHILADELPHIA, May 19, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, “the Company”, “Avacta”), a clinical stage biopharmaceutical company developing pre|CISION, a tumor-activated…
globenewswire.com Avacta presents new comparisons of pre|CISION® payload release vs approved ADCs and AVA6207 dual payload delivery at Science Day 2026 LONDON and PHILADELPHIA, May 06, 2026 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT, "the Company", "Avacta"), a clinical stage biopharmaceutical company developing pre|CISION®, a…
defenseworld.net Avacta Group (OTCMKTS:AVCTF) Stock Price Down 5.3% – Here’s What Happened Avacta Group Plc (OTCMKTS:AVCTF - Get Free Report) shares dropped 5.3% on Friday. The company traded as low as $0.8151 and last traded at $0.8151. Approximately 4,000 shares were traded during…
seekingalpha.com Avacta Group Plc (AVCTF) Discusses Initial Faridoxorubicin Phase Ib Data and Safety Profile in Salivary Gland Cancer Transcript Avacta Group Plc (AVCTF) Discusses Initial Faridoxorubicin Phase Ib Data and Safety Profile in Salivary Gland Cancer Transcript
defenseworld.net Avacta Group (OTCMKTS:AVCTF) Trading 1.2% Higher – What’s Next? Avacta Group Plc (OTCMKTS:AVCTF - Get Free Report) shares were up 1.2% during mid-day trading on Thursday. The stock traded as high as $0.98 and last traded at $0.98. Approximately 200 shares changed…
defenseworld.net Short Interest in Avacta Group Plc (OTCMKTS:AVCTF) Rises By 61.6% Avacta Group Plc (OTCMKTS:AVCTF - Get Free Report) was the target of a large increase in short interest in October. As of October 15th, there was short interest totaling 89,200 shares, an increase of…
seekingalpha.com Avacta Group Plc (AVCTF) Q2 2025 Earnings Call Transcript Avacta Group Plc (OTCPK:AVCTF) Q2 2025 Earnings Call September 30, 2025 9:00 AM EDT Company Participants Christina Coughlin - CEO & Executive Director Brian Hahn - CFO & Company Secretary…
globenewswire.com Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development LONDON and PHILADELPHIA, July 01, 2025 (GLOBE NEWSWIRE) -- Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs, today announces the appointment of…
seekingalpha.com Avacta Group Plc (AVCTF) Preliminary Q4 2024 Earnings Conference Call Transcript Avacta Group Plc Q2 2025 Earnings Conference Call June 6, 2025 6:00 AM ET Company Participants Brian M. Hahn - Chief Financial Officer Christina Marie Coughlin - CEO, Interim Chief Medical Officer…
seekingalpha.com Avacta Group Plc (AVCTF) Q2 2024 Earnings Call Transcript Avacta Group Plc (OTCPK:AVCTF) Q2 2024 Earnings Conference Call September 30, 2024 6:00 AM ET Company Participants Christina Coughlin - Chief Executive Officer Conference Call Participants Operator…
seekingalpha.com Avacta Group PLC (AVCTF) Q4 2023 Earnings Call Transcript Avacta Group PLC (OTCPK:AVCTF) Q4 2023 Earnings Conference Call April 30, 2024 7:30 AM ET Company Participants Christina Coughlin - CEO Tony Gardiner - CFO Conference Call Participants Operator Good…